Skip to content
Head to head

Royal Philips vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: PHG · ABT

Updated 8 minutes ago

1-year performance, rebased to 100

PHG +6.3%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories earns the most per share.
PHGABT
Snapshot
SectorMedical DevicesMedical Devices
Last price28.61103.00
Change today-2.19%-0.84%
1-year return+11.3%-15.4%
Market cap$27.97B$178.39B
52-week range23.62 – 32.2180.89 – 126.70
Valuation
P/E (TTM)26.3438.29
P/E percentile, own 5-yr range82nd99th
P/B2.203.50
Dividend yield3.44%2.41%
Profitability & growth
EPS (TTM)1.023.72
Net profit (TTM)$997.17M$6.44B
Revenue (TTM)$17.76B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+2.1%+14.5%
Gross margin46.4%56.9%
Operating margin8.9%13.8%
Net margin5.4%9.7%
Free cash flow (TTM)$1.83B$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership61.0%81.2%
Insider activity (12mo)0 buy / 0 sell36 buy / 12 sell
Short interest (% of float)0.2%1.1%
Analyst consensus100% hold (1)93% buy / 7% hold (15)
Analyst price target--$122 (+18%)
StockVane view
StockVane Quant RatingC (52)D (22)
Company
Employees66,954115,000
Founded18911900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.